Project Mercury Impact: A toolkit for new facioscapulohumeral muscular dystrophy trial sites
Facioscapulohumeral muscular dystrophy (FSHD) is at a turning point, with multiple disease-modifying therapies in development. To ensure global access, clinical trial readiness across diverse regions is critical. This publication idea was initiated through Project Mercury in collaboration with others to offer a practical toolkit for new trial sites. Drawing on